Drug developers heavily rely on a number of broadcasting channels, which include direct-to-consumer (DTC) advertisements, product websites and conferences, to promote the use of their proprietary drugs. The importance of such promotions is evident from the fact that the US pharmaceutical industry spent over USD 4.5 billion in DTC advertisements in the first three quarters of...